FARRELL MICHAEL J. (Chief Executive Officer) sold 1.0% of their position (4.99K shares) of RESMED INC on the open market
Open‑market sale worth $1.13M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/8/2026ACC: 0000943819-26-000085
Officer· Chief Executive Officer
Since Aug 2018
-4.99K
Net shares
Net seller
$1.13M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
4.99K acquired · 9.98K disposed
Non-Derivative Transactions2
ResMed Common Stock
Direct
Shares
+4.99K
Price / share
$146.34
Trade value
$730.38K
% of position
1.0%
10/7/2026
479.80K→484.79K
ResMed Common Stock
Direct
Shares
−4.99K
Price / share
$226.33
Trade value
$1.13M
% of position
1.0%
10/7/2026
484.79K→479.80K
Total
Net shares
+0.00
Net value
-$399.25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock Direct | 10/7/2026 | M · Option Exercise | +4.99K | $146.34 | $730.38K | 1.0% | 479.80K | 484.79K |
| ResMed Common Stock Direct | 10/7/2026 | S · Sale | −4.99K | $226.33 | $1.13M | 1.0% | 484.79K | 479.80K |
| Total | +0.00 | -$399.25K | ||||||
Derivative Transactions1
ResMed Common Stock Options
Direct
Converts to
ResMed Common Stock
4.99K shares
Shares
−4.99K
Strike price
146.34
Held after
4.99K
Exercisable
—
10/7/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| ResMed Common Stock Options Direct | ResMed Common Stock4.99K shares | 10/7/2026 | M · Option Exercise | −4.99K | 146.34 | — | 4.99K |
Non-Derivative Holdings (Post-Transaction)1
ResMed Common Stock
IndirectShares owned2.09K
Total
2.09K indirect2.09K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| ResMed Common Stock | 2.09K | Indirect |
| Total | 2.09K | 2.09K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported